✦ LIBER ✦

Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis

✍ Scribed by M. BRUNNER; H. VOGELSANG; R. GREINWALD; K. KLETTER; H. KVATERNIK; C. SCHROLNBERGER; H.-G. EICHLER; H. BRUNNER; R. DUDCZAK; M. MÜLLER

Book ID: 108604178
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 125 KB
Volume: 22
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2005.02571.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and retrograde colonic

Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis

✍ M. NYMAN-PANTELIDIS; Å. NILSSON; Z. G-WAGNER; O. BORGA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB

The effect of mesalazine therapy on qual

The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis

✍ E. J. IRVINE; C.-H. YEH; D. RAMSEY; A. L. STIRLING; P. D. R. HIGGINS 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Comparison of the efficacy and safety of

Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis

✍ P. R. GIBSON; B. FIXA; B. PEKÁRKOVÁ; M. BÁTOVSKÝ; G. RADFORD-SMITH; J. TIBITANZL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Safety and tolerability of a modified fi

Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study

✍ Vladislaw Muratov; Joachim Lundahl; Aleksandra Mandic-Havelka; Kerstin Elvin; Åk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract Cellsorba™ is a medical device for leukocytapheresis (LCAP) treatment of ulcerative colitis (UC). Cellsorba™ EX Global type has been developed from Cellsorba E for intended use with ACD‐A as anticoagulant. We evaluated safety and efficacy of the modified Cellsorba using ACD‐A in a pilot

Twenty-four-hour manometric study of col

Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions

✍ Gabrio Bassotti; Giuseppe de Roberto; Fabio Chistolini; Francis Sietchiping-Nzep 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 116 KB